Yixintai treats chronic heart failure in rats by regulating gut microbiota and bile acid
These findings suggest that YXT exerts its therapeutic benefits by reshaping the gut microbiota, modulating bile acid metabolism, and activating TGR5.
Authors
- Qinghua Zeng (ORCID: https://orcid.org/0009-0006-0556-3322)
- Ya Li (ORCID: https://orcid.org/0009-0005-8684-9308)
- Z. Wang (ORCID: https://orcid.org/0009-0001-6410-4672)
- Yuan Hui (ORCID: https://orcid.org/0009-0006-1815-5192)
- Min Shi (ORCID: https://orcid.org/0000-0001-5928-8932)
- Zhihua Guo (ORCID: https://orcid.org/0000-0001-8966-7415)
- Aisi Huang
- Jiaming Wei
- Chengxin Liu (ORCID: https://orcid.org/0009-0003-9011-2048)
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.3389/fmicb.2025.1672313
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Key Research and Development Program of Hunan Province of China